0.1.Kamal Saud,et al.WCN25-2592：Comparison of the clinical profile of IgA nephropathy with other primary glomerulonephritis in nepali patients undergoing native kidney biopsy. 2.V. Akshay, et al.WCN25-1716 RENAL SHEAR WAVE ELASTOGRAPHY AS A NOVEL MARKER OF CHRONICITY AND RESPONSE TO TREATMENT IN LUPUS NEPHRITIS IN A TERTIARY CARE CENTER IN SOUTH INDIA,Kidney International Reports,Volume 10, Issue 2, Supplement,2025,Page S163,ISSN 2468-0249. 3.Nikhil Ingle, et al.WCN25-2492 PREDICTORS OF TREATMENT RESPONSE IN LUPUS NEPHRITIS: AN OBSERVATIONAL STUDY,Kidney International Reports,Volume 10, Issue 2, Supplement,2025,Pages S258-S259,ISSN 2468-0249. 4.Nikolay Bulanov, et al.WCN25-266 Performance of the different prediction tools for ANCA-associated glomerulonephritis: a retrospective cohort study, Kidney International Reports,Volume 10, Issue 2, Supplement,2025,Pages S172-S173,ISSN 2468-0249. 5.Luis Alberto Céspedes Limachi, et al.WCN25-945 PROGNOSTIC OF THE PERSISTENCE OF HEMATURIA AND PROTEINURIA AFTER INDUCTION IN VASCULITIS ASSOCIATED WITH ANCA IN THE NEPHROLOGY SERVICE, HOSPITAL DE CLÍNICAS UNIVERSITARIO, BOLIVIA,Kidney International Reports,Volume 10, Issue 2, Supplement,2025,Pages S186-S187,ISSN 2468-0249. 6.Tonmay Barai, et al.WCN25-4316 CLINICAL PROFILE AND TREATMENT OUTCOMES OF IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS AND C3 GLOMERULONEPHRITIS IN A TERTIARY CARE CENTER,Kidney International Reports,Volume 10, Issue 2, Supplement,2025,Pages S237-S239,ISSN 2468-0249.